Bandwidth Inc vs Cronos Group Inc — how do they compare? Bandwidth Inc trades at $51.51 (market cap $1.66B), while Cronos Group Inc trades at $3.08 (market cap $1.14B). The key difference: Bandwidth Inc is the larger of the two by market cap, and Cronos Group Inc is trading nearer its 52-week high, Bandwidth Inc nearer its low. Which is the better fit depends on your goals.
| BAND | CRON | |
|---|---|---|
Market Cap | $1.66B | $1.14B |
Sector | Technology | Health |
52-Week High | $78.44 | $3.27 |
52-Week Low | $12.82 | $2.30 |
Enterprise Value | $2.04B | $341.13M |
Signals from Pluang's Aura AI — not financial advice
Bandwidth (BAND) trades at $49.96, up 11.79% in 24 hours, with bullish technical signals and strong analyst support. Recent Q2 2026 earnings beat estimates, driven by AI-driven communications demand, with revenue up 22% year-over-year. The company raised its 2026 outlook, reflecting operational momentum and margin expansion.
Outlook is positive with a $75.25 consensus price target, though risks include thin net margins and high valuation multiples. Growth hinges on AI adoption and enterprise wins, but competitive pressures and execution challenges remain key watchpoints for investors.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Bandwidth is a global communications software company. Its CPaaS platform allows enterprises to embed voice, messaging, and 911 emergency services directly into their software applications via robust APIs.
Read more on BAND →Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →